CSIMarket
 


Oncovista Innovative Therapies, Inc  (OVIT)
Other Ticker:  
 
 

OVIT's Net Income Growth by Quarter and Year

Oncovista Innovative Therapies, Inc's Net Income results by quarter and year




OVIT Net Income (in millions $) FY 2015 FY 2014 FY 2013 FY 2012
IV Quarter December - -1.57 -0.38 -0.35
III Quarter September -0.33 0.23 -0.37 -0.37
II Quarter June -1.10 -0.89 -0.26 -0.25
I Quarter March -0.28 -0.31 -0.45 -0.66
FY   -1.71 -2.54 -1.46 -1.63



OVIT Net Income third quarter 2015 Y/Y Growth Comment
Oncovista Innovative Therapies, Inc in the third quarter 2015 recorded net loss of $ -0.33 millions.

According to the results reported in the third quarter 2015, Oncovista Innovative Therapies, Inc achieved the best Net Income growth in Biotechnology & Pharmaceuticals industry. While Oncovista Innovative Therapies, Inc' s Net Income no change of % ranks overall at the positon no. in the third quarter 2015.




OVIT Net Income ( Y/Y Growth %) 2015
2014 2013 2012
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Oncovista Innovative Therapies, Inc's third quarter 2015 Net Income $ -0.33 millions OVIT's Income Statement
Oncovista Innovative Therapies, Inc's third quarter 2014 Net Income $ 0.23 millions Quarterly OVIT's Income Statement
New: More OVIT's historic Net Income Growth >>


OVIT Net Income (Quarter on Quarter Growth %)

2015
2014 2013 2012
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Net Income third quarter 2015 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Income third quarter 2015 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Income by Quarter for the Fiscal Years 2012, 2013, 2014, 2015

Oncovista Innovative Therapies, Inc's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


OVIT's III. Quarter Q/Q Net Income Comment
Although Oncovista Innovative Therapies, Inc in the III. Quarter 2015 admitted net loss of $ -0.33 millions, some analyst mentioned, that current results show recovery compare to the -1.10 millions in the second quarter.

Within Biotechnology & Pharmaceuticals industry Oncovista Innovative Therapies, Inc achieved highest sequential Net Income growth. While Oncovista Innovative Therapies, Inc's Net Income growth quarter on quarter, overall rank is .


Net Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


OVIT's III. Quarter Q/Q Net Income Comment
Even if Oncovista Innovative Therapies, Inc in the III. Quarter 2015 showed net loss of $ -0.33 millions, some analyst mentioned, that current results show recovery compare to the -1.10 millions in the second quarter.

Within Biotechnology & Pharmaceuticals industry Oncovista Innovative Therapies, Inc achieved highest sequential Net Income growth. While Oncovista Innovative Therapies, Inc's Net Income growth quarter on quarter, overall rank is .


Oncovista Innovative Therapies, Inc's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Sep 30 2015)
12 Months Ending
(Jun 30 2015)
12 Months Ending
(Mar 31 2015)
12 Months Ending
(Dec 31 2014)
12 Months Ending
(Sep 30 2014)
Cumulative Net Income 12 Months Ending $ -3.27 $ -2.72 $ -2.51 $ -2.54 $ -1.35
Y / Y Net Income Growth (TTM) - - - - -
Year on Year Net Income Growth Overall Ranking # # # # #
Seqeuential Net Income Change (TTM) - - - - -
Seq. Net Income Growth (TTM) Overall Ranking # # # # #




Cumulative Net Income growth Comment
Oncovista Innovative Therapies, Inc' has realized cumulative trailing twelve months net loss of $ -3 millions in the Sep 30 2015 period.
The business is detiriorating as the cumulative net loss is getting bigger from $ -2.72 millions in TTM ending quarter Jun 30 2015 and $ -1.944346 millions for the twelve months ending in the quarter Sep 30 2014.

Oncovista Innovative Therapies, Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Income growth Comment
Oncovista Innovative Therapies, Inc' has realized cumulative trailing twelve months net loss of $ -3 millions in the Sep 30 2015 period.
The situation is getting worse as the cumulative net loss is becoming larger from $ -2.72 millions for the period from Jun 30 2015 to Sep 30 2014 and $ -1.944346 millions from the TTM period ending Sep 30 2014 Melissa Larsson told.

Oncovista Innovative Therapies, Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Income Growth
Biotechnology & Pharmaceuticals Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
OVIT's Net Income Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for OVIT's Competitors
Net Income Growth for Oncovista Innovative Therapies, Inc's Suppliers
Net Income Growth for OVIT's Customers

You may also want to know
OVIT's Annual Growth Rates OVIT's Profitability Ratios OVIT's Asset Turnover Ratio OVIT's Dividend Growth
OVIT's Roe OVIT's Valuation Ratios OVIT's Financial Strength Ratios OVIT's Dividend Payout Ratio
OVIT's Roa OVIT's Inventory Turnover Ratio OVIT's Growth Rates OVIT's Dividend Comparisons



Companies with similar Net Income no change for the quarter ending Sep 30 2015 within Healthcare SectorY/Y Change %Net Income for the quarter ending Sep 30 2015
Amedisys Inc -0.26%$ -0.256 millions
Bristol myers Squibb Company-0.27%$ -0.273 millions
3m Company-0.38%$ -0.384 millions
Nutrastar International Inc.-1.13%$ -1.130 millions
Resmed Inc -3.43%$ -3.431 millions
Ufp Technologies Inc -3.58%$ -3.582 millions
Lannett Company Inc-5.02%$ -5.019 millions
Bio techne Corp-5.02%$ -5.019 millions
Hca Healthcare Inc -6.22%$ -6.219 millions
Phibro Animal Health Corporation-8.44%$ -8.437 millions
National Research Corporation-9.07%$ -9.073 millions
Electromed Inc -9.69%$ -9.686 millions
American Shared Hospital Services-10.32%$ -10.317 millions
Addus Homecare Corporation-10.81%$ -10.812 millions
Lifeloc Technologies Inc -11.84%$ -11.840 millions
Psychemedics Corp-13.14%$ -13.144 millions
Aac Holdings, Inc.-13.88%$ -13.877 millions
Mylan N v -14.13%$ -14.125 millions
Idexx Laboratories Inc-15.21%$ -15.210 millions
Msa Safety Incorporated-18.84%$ -18.844 millions
Pacific Health Care Organization Inc -19.15%$ -19.154 millions
Pfizer Inc-19.77%$ -19.767 millions
Community Health Systems Inc -20.21%$ -20.213 millions
Align Technology inc -27.80%$ -27.796 millions
Johnson and Johnson-29.29%$ -29.290 millions
Ani Pharmaceuticals Inc-32.42%$ -32.419 millions
Merit Medical Systems Inc-37.94%$ -37.944 millions
Becton Dickinson And Company-39.53%$ -39.535 millions
Surmodics Inc-42.06%$ -42.065 millions
Integrated Biopharma Inc-50.31%$ -50.309 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com